EXICURE, INC. (XCUR) SEC Filings & Financial Intelligence
EXICURE, INC. (XCUR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XCUR
CIK: 1698530
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerNina Quarequio
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001193125-26-392654 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-352011 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-06-23 | PRIMARY DOCUMENT | 0002046701-26-000009 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-17 | — | SCHEDULE 13D/A Filing | 0002046701-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-30 | 8-K | 0001193125-26-290264 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001698530-26-000060 | View SEC Doc Filr Page |
| 10-Q | 2026-05-29 | 2026-03-31 | 10-Q | 0001698530-26-000057 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q | 0001698530-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-04-10 | 2026-04-08 | 8-K | 0001698530-26-000036 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-04-02 | 8-K | 0001698530-26-000034 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-25 | 8-K | 0001698530-26-000031 | View SEC Doc Filr Page |
| 10-K | 2026-03-25 | 2025-12-31 | 10-K | 0001698530-26-000028 | View SEC Doc Filr Page |
| 8-K | 2026-03-25 | 2026-03-25 | 8-K | 0001698530-26-000026 | View SEC Doc Filr Page |
| 4 | 2026-02-19 | 2026-02-16 | FORM 4 | 0001973899-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-02-17 | 2026-02-11 | 8-K | 0001698530-26-000013 | View SEC Doc Filr Page |
| 8-K | 2026-02-10 | 2026-02-06 | 8-K | 0001698530-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-01-22 | 2026-01-16 | 8-K | 0001698530-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-21 | — | SCHEDULE 13D/A Filing | 0002046701-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-01-21 | 2026-01-21 | PRIMARY DOCUMENT | 0002046701-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-20 | — | SCHEDULE 13D/A Filing | 0002046701-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-01-20 | 2026-01-16 | PRIMARY DOCUMENT | 0002046701-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-09 | — | SCHEDULE 13D/A Filing | 0002046701-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-01-08 | 2026-01-07 | PRIMARY DOCUMENT | 0002046701-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-12-10 | — | SCHEDULE 13G/A Filing | 0001013594-25-001502 | View SEC Doc Filr Page |
| 4 | 2025-12-10 | 2025-12-08 | FORM 4 | 0001013594-25-001501 | View SEC Doc Filr Page |